Article History
Received: 19 June 2024
Accepted: 25 November 2024
First Online: 6 December 2024
Declarations
:
: Ethical approval is not applicable for this report as the patient identifiers have not been revealed.
: Consent was obtained from the patient for an off-label indication of low-dose nivolumab and also reported this case in scientific journals. The identity of the patient is not revealed.
: Dr. Prasanth Penumadu is a Section Editor in the Indian Journal of Surgical Oncology. The other authors declare that they have no competing financial or personal relationships that could have influenced this work.